Abstract
Cystic neoplasms of pancreas consist approximately 15-20%of all cystic lesions. The most prominent tumors are serous, mucinous and intraductal papillary mucinous ones. In the absence of pancreatitis history, all of the cystic pancreatic lesions must be accepted as neoplasms until otherwise proven.
Diagnostic process is difficult and has an outmost importance for choosing the treatment modality. Whereas serous cystic tumors are generally of benign character, mucinous ones are either premalignant or malignant.
Asymptomatic serous cystic neoplasms may be followed without treatment. Mucinous cystic and intraductal papillary mucinous neoplasms should be resected. The best treatment for these tumors is anatomic resection. The prognosis is quite good if there is no tumor invasion. Invasive tumors have a worse prognosis and may be followed with CT and/or endoscopic ultrasonography.
Keywords:
Mucinous, serous, intaductal papillary, cystic neoplasm, pancreas
References
1Horvath KD, Chabot JA. An agressive resectional approach to cystic neoplasms of the pancreas. Am J Surg 1999; 178:269-274.
2Compagno J, Oertel JE. Microcystic adenomas of the pancreas (glycogen-rich cystadenomas): a clinicopathologic study of 34 cases. Am J Clin Pathol 1978; 69:289-298.
3Ohhashi K, Murakami Y, Takekoshi T, et al. Four cases of mucin producing cancer of the pancreas on specific findings of the papilla of Vater. Prog Dig Endosc 1982; 20:348-351.
4Sarr MG, Murr M, Smyrk TC, et al. Primary cystic neoplasms of the pancreas. Neoplastic disorders of emerging importance-current state-of-the-art and unanswered questions. J Gastrointest Surg 2003; 7:417-428.
5Sarr MG, Carpenter HA, Prabhakar LP, et al. Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: can one reliably differentiate benign from malignant (or premalignant) neoplasms? Ann Surg 2000; 231:205-212.
6Grieshop NA, Wiebke EA, Kratzer SS, Madura JA. Cystic neoplasms of the pancreas. Am Surg 1994; 60:509-514.
7Leung KL, Lau WY, Cooper JE, Li AK. Mucinous cystadenocarcinoma of the pancreas: an uncommon presentation with hemobilia. Gastrointest Endosc 1994; 40:632-634.
8Sakorafas GH, Sarr MG. Cystic neoplasms of the pancreas; what a clinician should know. Cancer Treat Rev 2005; 31:507-535.
9Sakorafas GH, Sarr MG. Cystic neoplasms of the pancreas: The practice of general surgery. Philedelphia: W.B. Saunders, 2002. p.771-776.
10Sarr MG, Kendrick ML, Nagorney DM, et al. Cystic neoplasms of the pancreas: benign to malignant epithelial neoplasms. Surg Clin North Am 2001; 81:497-509.
11Thompson LD, Becker RC, Przygodzki RM, et al. Mucinous cystic neoplasm (mucinous cystadenocarcinoma of low-grade malignant potential) of the pancreas: a clinicopathologic study of 130 cases. Am J Surg Pathol 1999; 23:1-16.
12Zamboni G, Scarpa A, Bogina G, et al. Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am J Surg Pathol 1999; 23:410-422.
13Sarr MG, Sakorafas GH. Cystic neoplasms of the pancreas. Germany: Springer, 2000. p.297-303.
14Kimura W, Sasahira N, Yoshikawa T, et al. Duct-ectatic type of mucin producing tumor of the pancreas--new concept of pancreatic neoplasia. Hepatogastroenterology 1996; 43:692-709.
15Warshaw AL, Compton CC, Lewandrowski K, et al. Cystic tumors of the pancreas. New clinical, radiologic, and pathologic observations in 67 patients. Ann Surg 1990; 212:432-443.
16Yamao K, Nakamura T, Suzuki T, et al. Endoscopic diagnosis and staging of mucinous cystic neoplasms and intraductal papillary-mucinous tumors. J Hepatobiliary Pancreat Surg 2003; 10:142-146.
17Michael H, Gress F. Diagnosis of cystic neoplasms with endoscopic ultrasound. Gastrointest Endosc Clin N Am 2002; 12:719-733.
18Gress F, Gottlieb K, Cummings O, et al. Endoscopic ultrasound characteristics of mucinous cystic neoplasms of the pancreas. Am J Gastroenterol 2000; 95:961-965.
19Mallery JS, Centeno BA, Hahn PF, et al. Pancreatic tissue sampling guided by EUS, CT/US, and surgery: a comparison of sensitivity and specificity. Gastrointest Endosc 2002; 56:218-224.
20Freeny PC, Weinstein CJ, Taft DA, et al. Cystic neoplasms of the pancreas: new angiographic and ultrasonographic findings. AJR Am J Roentgenol 1978; 131:795-802.
21Le Borgne J, de Calan L, Partensky C. Cystadenomas and cystadenocarcinomas of the pancreas: a multiinstitutional retrospective study of 398 cases. French Surgical Association. Ann Surg 1999; 230:152-161.
22Recine M, Kaw M, Evans DB, et al. Fine-needle aspiration cytology of mucinous tumors of the pancreas. Cancer 2004; 102:92-99.
23Young NA, Villani MA, Khoury P, et al. Differential diagnosis of cystic neoplasms of the pancreas by fine-needle aspiration. Arch Pathol Lab Med 1991; 115:571-577.
24Lewandrowski KB, Southern JF, Pins MR, et al. Cyst fluid analysis in the differential diagnosis of pancreatic cysts. A comparison of pseudocysts, serous cystadenomas, mucinous cystic neoplasms, and mucinous cystadenocarcinoma. Ann Surg 1993; 217:41-47.
25Sperti C, Pasquali C, Pedrazzoli S, et al. Expression of mucin-like carcinoma-associated antigen in the cyst fluid differentiates mucinous from nonmucinous pancreatic cysts. Am J Gastroenterol 1997; 92:672-675.
26Hammel P, Voitot H, Vilgrain V, et al. Diagnostic value of CA 72-4 and carcinoembryonic antigen determination in the fluid of pancreatic cystic lesions. Eur J Gastroenterol Hepatol 1998; 10:345-348.
27Martin I, Hammond P, Scott J, et al. Cystic tumours of the pancreas. Br J Surg 1998; 85:1484-1486.
28Talamini MA, Moesinger R, Yeo CJ, et al. Cystadenomas of the pancreas: is enucleation an adequate operation? Ann Surg 1998; 227:896-903.
29Katoh H, Rossi RL, Braasch JW, et al. Cystadenoma and cystadenocarcinoma of the pancreas. Hepatogastroenterology 1989; 36:424-430.
30Hodgkinson DJ, ReMine WH, Weiland LH. Pancreatic cystadenoma. A clinicopathologic study of 45 cases. Arch Surg 1978; 113:512-519.
31Pyke CM, van Heerden JA, Colby TV, et al. The spectrum of serous cystadenoma of the pancreas. Clinical, pathologic, and surgical aspects. Ann Surg 1992; 215:132-139.
32Delcore R, Thomas JH, Forster J, Hermreck AS. Characteristics of cystic neoplasms of the pancreas and results of aggressive surgical treatment. Am J Surg 1992; 164:437-441.
33Iacono C, Bortolasi L, Serio G. Is there a place for central pancreatectomy in pancreatic surgery? J Gastrointest Surg 1998; 2:509-516.
34Aranha GV. Central (middle segment) pancreatectomy: a suitable operation for small lesions of the neck of the pancreas. Hepatogastroenterology 2002; 49:1713-1715.
35Molino D, Perrotti P, Antropoli C, et al. Central segmental pancreatectomy in benign and borderline neoplasms of the pancreatic isthmus and body. Chir Ital 2001; 53:319-325.
36Kimura W, Fuse A, Hirai I, et al. Spleen-preserving distal pancreatectomy with preservation of the splenic artery and vein for intraductal papillary- mucinous tumor (IPMT): three interesting cases. Hepatogastroenterology 2003; 50:2242-2245.
37Le Borgne J. Pancreatic cystadenoma. Ann Chir 1989; 43:451-457.
38Kiely JM, Nakeeb A, Komorowski RA, et al. Cystic pancreatic neoplasms: enucleate or resect? J Gastrointest Surg 2003; 7:890-897.
39Kobari M, Egawa S, Shibuya K, et al. Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management. Arch Surg 1999; 134:1131-1136.
40Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity. Ann Surg 2001; 234:313-321.
41Paye F, Sauvanet A, Terris B, et al. Intraductal papillary mucinous tumors of the pancreas: pancreatic resections guided by preoperative morphological assessment and intraoperative frozen section examination. Surgery 2000; 127:536-544.
42Salvia R, Fernandez-del Castillo C, Bassi C, et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 2004; 239:678-685.
43Terris B, Ponsot P, Paye F, et al. Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol 2000; 24:1372-1377.
44Traverso LW, Peralta EA, Ryan JA, Jr., Kozarek RA. Introductal neoplasms of the pancreas. Am J Surg 1998; 175:426-432.
45Shima Y, Mori M, Takakura N, et al. Diagnosis and management of cystic pancreatic tumours with mucin production. Br J Surg 2000; 87:1041-1047.
46Obara T, Maguchi H, Saitoh Y, et al. Mucin-producing tumor of the pancreas: natural history and serial pancreatogram changes. Am J Gastroenterol 1993; 88:564-569.
47Cuillerier E, Cellier C, Palazzo L, et al. Outcome after surgical resection of intraductal papillary and mucinous tumors of the pancreas. Am J Gastroenterol 2000; 95:441-445.
48George DH, Murphy F, Michalski R, Ulmer BG. Serous cystadenocarcinoma of the pancreas: a new entity? Am J Surg Pathol 1989; 13:61-66.
49Doberstein C, Kirchner R, Gordon L, et al. Cystic neoplasms of the pancreas. Mt Sinai J Med 1990; 57:102-105.